J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...
Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...
More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...
Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...
Children conceived via assisted reproductive technology (ART) have a higher risk for developing atopic disease.
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...
Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These ...
The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.
Phototherapy, also called light therapy, is a treatment that uses ultraviolet light from a medical device to relieve certain skin conditions. It can ease itching, redness, and swelling in some adults ...
Atopic dermatitis (AD) is a chronic skin condition that causes dry skin and rashes. Effective management is crucial for a higher quality of life and better sleep. Treatment options for AD range from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback